HIV prevention: What have we learned from community experiences in concentrated epidemics?

Journal of the International AIDS Society

Volumn 11, Issue 1, 2008, Pages 5-

  Spire, Bruno ^a,b,c   de Zoysa, Isabelle ^d   Himmich, Hakima ^e  

^a AIX MARSEILLE UNIV   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c AIDES   (France)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e ALCS   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953833141     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-11-5     Document Type: Review

References (62)

1. Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J: The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest 2008, 118:1244-1254.
2. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005, 2:e298.
3. Quigley MA, Weiss HA, Hayes RJ: Male circumcision as a measure to control HIV infection and other sexually transmitted diseases. Curr Opin Infect Dis 2001, 14:71-75.
4. Wodak A: Controlling HIV among injecting drug users: the current status of harm reduction. HIV AIDS Policy Law Rev 2006, 11:77-80.
5. Wodak A, McLeod L: The role of harm reduction in controlling HIV among injecting drug users. Aids 2008, 22(Suppl 2):S81-92.
6. Weller S, Davis K: Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002:CD003255.
7. Underhill K, Montgomery P, Operario D: Sexual abstinence only programmes to prevent HIV infection in high income countries: systematic review. Bmj 2007, 335:248.
8. Robin L, Dittus P, Whitaker D, Crosby R, Ethier K, Mezoff J, et al.: Behavioral interventions to reduce incidence of HIV, STD, and pregnancy among adolescents: a decade in review. J Adolesc Health 2004, 34:3-26.
9. Shelton JD, Halperin DT, Nantulya V, Potts M, Gayle HD, Holmes KK: Partner reduction is crucial for balanced “ABC” approach to HIV prevention. Bmj 2004, 328:891-893.
10. Roth J, Krishnan SP, Bunch E: Barriers to condom use: results from a study in Mumbai (Bombay), India. AIDS Educ Prev 2001, 13:65-77.
11. Stockman JK, Schwarcz SK, Butler LM, de Jong B, Chen SY, Delgado V, McFarland W: HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr 2004, 35:432-434.
12. Velter A: Enquête presse gaie, InVs. 2008.
13. Dougan S, Evans BG, Elford J: Sexually transmitted infections in Western Europe among HIV-positive men who have sex with men. Sex Transm Dis 2007, 34:783-790.
14. Osmond DH, Pollack LM, Paul JP, Catania JA: Changes in prevalence of HIV infection and sexual risk behavior in men who have sex with men in San Francisco: 1997 2002. Am J Public Health 2007, 97:1677-1683.
15. Belzer N, Bajos N: Survey on sexual behaviors of French people (2005–2006). Rapport final.
16. Baume CA: The relationship of perceived risk to condom use: why results are inconsistent. Soc Mar Q 2000, 6:33-42.
17. Buve A, Lagarde E, Carael M, Rutenberg N, Ferry B, Glynn JR, et al.: Interpreting sexual behaviour data: validity issues in the multicentre study on factors determining the differential spread of HIV in four African cities. Aids 2001, 15(Suppl 4):S117-126.
18. Spire B, Bouhnik AD, Obadia Y, Lert F: Concealment of HIV and unsafe sex with steady partner is extremely infrequent. Aids 2005, 19:1431-1433.
19. Kang MS, Buck J, Padian N, Posner SF, Khumalo-Sakutukwa G, Straten A van der: The importance of discreet use of the diaphragm to Zimbabwean women and their partners. AIDS Behav 2007, 11:443-451.
20. Parsons JT, Schrimshaw EW, Wolitski RJ, Halkitis PN, Purcell DW, Hoff CC, Gomez CA: Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. Aids 2005, 19(Suppl 1):S13-25.
21. Leobon A, Frigault LR: Frequent and systematic unprotected anal intercourse among men using the Internet to meet other men for sexual purposes in France: results from the “Gay Net Barometer 2006” survey. AIDS Care 2008, 20:478-484.
22. Chigwedere P, Seage GR, Lee TH, Essex M: Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials. AIDS Res Hum Retroviruses 2008, 24:827-837.
23. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000, 342:921-929.
24. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH: Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. Aids 2004, 18:81-88.
25. Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C: Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 2005, 40:96-101.
26. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM: Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008, 372:314-320.
27. Vernazza P, Hirshel N, Bernasconi E, Flepp M: Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletins des médecins suisses 2008, 89:165-169.
28. Kalichman SC, Di Berto G, Eaton L: Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm Dis 2008, 35:55-60.
29. Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C, et al.: New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 2008, 371:2183-2191.
30. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, et al.: Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society–USA panel. Top HIV Med 2006, 14:827-843.
31. Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, Montaner JS: Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 2008, 198:59-67.
32. Moatti JP, Prudhomme J, Traore DC, Juillet-Amari A, Akribi HA, Msellati P: Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Cote d'Ivoire. Aids 2003, 17(Suppl 3):S69-77.
33. Dia A: XVII International AIDS conference, Mexico, August 3rd -August 8th Poster TUPE0843.
34. Sarna A, Luchters SM, Geibel S, Kaai S, Munyao P, Shikely KS, et al.: Sexual risk behaviour and HAART: a comparative study of HIV-infected persons on HAART and on preventive therapy in Kenya. Int J STD AIDS 2008, 19:85-89.
35. Pradier C, Bentz L, Spire B, Tourette-Turgis C, Morin M, Souville M, et al.: Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials 2003, 4:121-131.
36. Spire B, Carrieri M, Sopha P, Protopopescu C, Prak N, Quillet C, et al.: Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment. Antivir Ther 2008, 13(5):697-703.
37. Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P, et al.: Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001, 28:445-449.
38. Carrieri MP, Leport C, Protopopescu C, Cassuto JP, Bouvet E, Peyramond D, et al.: Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acquir Immune Defic Syndr 2006, 41:477-485.
39. Duran S, Spire B, Raffi F, Walter V, Bouhour D, Journot V, et al.: Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2001, 2:38-45.
40. Bouhnik AD, Preau M, Schiltz MA, Peretti-Watel P, Obadia Y, Lert F, Spire B: Unsafe sex with casual partners and quality of life among HIV-infected gay men: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA). J Acquir Immune Defic Syndr 2006, 42:597-603.
41. Desquilbet L, Deveau C, Goujard C, Hubert JB, Derouineau J, Meyer L: Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort. Aids 2002, 16:2329-2333.
42. Carrieri P, Spire B, Duran S, Katlama C, Peyramond D, Francois C, et al.: Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003, 32:38-47.
43. Vincent E, Bouhnik AD, Carrieri MP, Rey D, Dujardin P, Granier F, et al.: Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up. Aids 2004, 18:1321-1325.
44. Protopopescu C: XVII International AIDS conference, Mexico, August 3rd -August 8th Poster THPE0815.
45. Galvan FH, Bing EG, Bluthenthal RN: Accessing HIV testing and care. J Acquir Immune Defic Syndr 2000, 25(Suppl 2):S151-156.
46. Marks G, Crepaz N, Senterfitt JW, Janssen RS: Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005, 39:446-453.
47. Sherr L, Lopman B, Kakowa M, Dube S, Chawira G, Nyamukapa C, et al.: Voluntary counselling and testing: uptake, impact on sexual behaviour, and HIV incidence in a rural Zimbabwean cohort. Aids 2007, 21:851-860.
48. WHO/UNAIDS: Guidance on Provider-initiated HIV Testing and Counselling in Health Facilities. 2007.
49. Bassett IV, Giddy J, Nkera J, Wang B, Losina E, Lu Z, et al.: Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr 2007, 46:181-186.
50. Matovu JK, Makumbi FE: Expanding access to voluntary HIV counselling and testing in sub-Saharan Africa: alternative approaches for improving uptake, 2001–2007. Trop Med Int Health 2007, 12:1315-1322.
51. Himmich H: Assises nationales de l'association de lutte contre le sida du Maroc. 2007.
52. Pilcher CD, Tien HC, Eron JJ Jr, Vernazza PL, Leu SY, Stewart PW, et al.: Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004, 189:1785-1792.
53. Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C, et al.: High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007, 195:951-959.
54. Pulerwitz J, Michaelis AP, Lippman SA, Chinaglia M, Diaz J: HIV-related stigma, service utilization, and status disclosure among truck drivers crossing the Southern borders in Brazil. AIDS Care 2008, 20:198-204.
55. Peretti-Watel P, Spire B, Pierret J, Lert F, Obadia Y: Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care 2006, 18:254-261.
56. Peretti-Watel P, Spire B, Obadia Y, Moatti JP: Discrimination against HIV-infected people and the spread of HIV: some evidence from France. PLoS ONE 2007, 2:e411.
57. Baral S, Sifakis F, Cleghorn F, Beyrer C: Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: a systematic review. PLoS Med 2007, 4:e339.
58. Sijetais [http://www.sijetaisseropositif.com/]
59. Parker RG: Empowerment, community mobilization and social change in the face of HIV/AIDS. Aids 1996, 10(Suppl 3):S27-31.
60. Barbot J: How to build an “active” patient? The work of AIDS associations in France. Soc Sci Med 2006, 62:538-551.
61. Ghose T, Swendeman D, George S, Chowdhury D: Mobilizing collective identity to reduce HIV risk among sex workers in Sonagachi, India: the boundaries, consciousness, negotiation framework. Soc Sci Med 2008, 67:311-320.
62. Cutler F: XVII International AIDS conference, Mexico, August 3rd -August 8th Poster WEPDE203.